Hi Abbas, I dont believe the newsletter is the cause of the...

Hi Abbas, I dont believe the newsletter is the cause of the market action today. The newsletter contains nothing negative imo. I believe all those with lots of shares to sell would be aware that the interim data is not sufficient statistically to determine a final efficacy result. They have another 12 months to go for the final results in the can003 and at the same time have started enrolments for can004 which involves a much larger patient group of 800 taken from 1000 enrolments. The can003 is also not a double blind trial which can004 will be.

From my reading of posts here everyone seems to be aware that this interim data is a guide to the can003 outcome which will be finalised by end of next year. What is important is that each stage of the trial gets a tick so as to justify continuance through to the final stage and hopefully FDA approval followed by commercialisation. The fact they are considering other cancers in the future mix is a positive also imo.

As retail investors, Its only natural that nerves can come into play close to significant announcements from the company but while I cant predict what the outcome will be I have seen nothing negative to this point. So whats behind todays market action? Buyers pulled out of the buy side and some unusual big sells occurred. I'm puzzled lol.